Anesthetic Drug Interactions: Implications for Dosing - PowerPoint PPT Presentation

1 / 60
About This Presentation
Title:

Anesthetic Drug Interactions: Implications for Dosing

Description:

Adapted from Tverskoy, Anesthesia and Analgesia 67:342-345, 1988 ... Jaap Vuyk, M.D., Ph.D., Martijn J. Mertens, M.D., Erik Olofsen, M.Sc. ... – PowerPoint PPT presentation

Number of Views:228
Avg rating:3.0/5.0
Slides: 61
Provided by: StevenL163
Category:

less

Transcript and Presenter's Notes

Title: Anesthetic Drug Interactions: Implications for Dosing


1
Anesthetic Drug InteractionsImplications for
Dosing
  • Steven L. Shafer, M.D.
  • Professor of AnesthesiaStanford University
  • Adjunct Professor of Biopharmaceutical
    SciencesUniversity of California at San Francisco

2
Acknowledgements
Don Stanski Jaap Vuyk Peter Glass Peter
Sebel Igor Kissin
Charles Minto Timothy Short Thomas Schnider Keith
Gregg Andrea Gentilini
3
Traditional View of Drug Interactions
Adapted from Tverskoy, Anesthesia and Analgesia
67342-345, 1988
4
Inhalational anesthetic - opioid interaction
Adapted from Glass and Sebel
5
Remifentanil MAC Reduction
Lang et al, Anesthesiology 85, 721-728, 1996
6
Propofol/Alfentanil Interaction
  • Adapted from Vuyk et al, Anesthesiology 838-22,
    1995
  • Characterizes the concentrations for
  • intubation
  • maintenance
  • on emergence
  • Concentrations are 50 response level

7
Optimal Propofol/Alfentanil
  • Infusion rates for propofol and alfentanil
  • Propofol levels during maintenance and at
    emergence from anesthesia
  • Alfentanil concentrations during maintenance and
    at emergence
  • Time from ending the infusion to awakening from
    anesthesia
  • The percent decrease in concentration required
    for emergence from anesthesia

Stanski and Shafer Anesthesiology 831-5, 1995
8
EEG vs therapeutic ranges
Billard V, Shafer SL. Control and Automation in
Anesthesia. 1995, Springer
9
Propofol / opioid technique
Stanski and Shafer Anesthesiology 831-5, 1995
Shafer SL, ASA Refresher Course, Chapter 19, 1996
10
Propofol/OpioidTime to Awakening
Alfentanil Technique
Remifentanil Technique
20
15
10
5
0
600

120
240
360
480
600
0
120
240
360
480
Time (Minutes)
Time (Minutes)
Shafer SL, ASA Refresher Course, Chapter 19, 1996
11
Propofol/OpioidInfusion rates
Alfentanil Technique
Remifentanil Technique
400
300
Remifentanil (ng/kg/min)
Alfentanil (ng/kg/min)
200
Propofol (mg/kg/min)
Propofol (mg/kg/min)
100
0
600

120
240
360
480
600
0
120
240
360
480
Time (Minutes)
Time (Minutes)
Shafer SL, ASA Refresher Course, Chapter 19, 1996
12
Propofol/OpioidPropofol Levels (mg/ml)
Alfentanil Technique
Remifentanil Technique
6
4
Maintenance
Maintenance
2
Emergence
Emergence
0
600

120
240
360
480
600
0
120
240
360
480
Time (Minutes)
Time (Minutes)
Shafer SL, ASA Refresher Course, Chapter 19, 1996
13
Propofol/OpioidPercent Decrease on Emergence
Alfentanil Technique
Remifentanil Technique
100
75
Remifentanil
Propofol
50
Propofol
25
Alfentanil
0
600

120
240
360
480
600
0
120
240
360
480
Time (Minutes)
Time (Minutes)
Shafer SL, ASA Refresher Course, Chapter 19, 1996
14
Propofol/Remifentanil TIVA
  • Remifentanil
  • 0.25 mg/kg/min
  • Propofol
  • 80 mg/kg/min
  • Requires controlled ventilation

Shafer SL, ASA Refresher Course, Chapter 19, 1996
  • Little tolerance for interruption of
    remifentanil or propofol infusion

15
Propofol Anesthesia and Rational Opioid Selection
Determination of Optimal EC50-EC95
Propofol-Opioid Concentrations that Assure
Adequate Anesthesia and a Rapid Return on
Consciousness
Jaap Vuyk, M.D., Ph.D., Martijn J. Mertens, M.D.,
Erik Olofsen, M.Sc., Anton G.L. Burm, M.Sc,
Ph.D. James G. Bovill, M.D., Ph.D., F.F.A.R.C.S.I.
Anesthesiology 1997 871549-62
16
Modeling of opioid/hypnotic interaction
Adapted from Vuyk et al, Anesthesiology 838-22,
1995
17
(No Transcript)
18
(No Transcript)
19
(No Transcript)
20
(No Transcript)
21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
24
(No Transcript)
25
Propofol/Alfentanil
60 min
10 min
600 min
300 min
26
Propofol/Fentanyl
60 min
10 min
600 min
300 min
27
Propofol/Sufentanil
60 min
10 min
600 min
300 min
28
Propofol/Remifentanil
60 min
10 min
600 min
300 min
29
10 Minute Infusion
Alfentanil
Fentanyl
Remifentanil
Sufentanil
30
60 Minute Infusion
Alfentanil
Fentanyl
Remifentanil
Sufentanil
31
300 Minute Infusion
Alfentanil
Fentanyl
Remifentanil
Sufentanil
32
600 Minute Infusion
Alfentanil
Fentanyl
Remifentanil
Sufentanil
33
Optimal Maintenance Propofol / Opioid
Concentrations
Sufentanil (ng/ml)
34
Propofol/Opioid Recovery
40
35
30
25
Fentanyl
Minutes for Recovery
20
Alfentanil
15
Sufentanil
10
5
Remifentanil
0
0
120
240
360
480
600
Infusion Duration (minutes)
35
Propofol/opioid vs Isoflurane/opioid
36
Propofol/opioid vs Isoflurane/opioid
37
Ketamine/Magnesium Interaction
  • Preemptive Analgesia Ketamine and Magnesium
    Reduce Postoperative Morphine Requirements After
    Abdominal Hysterectomy
  • Anesthesiology 1998 89A1163
  • 4 groups
  • Placebo, MgSO4 2 gms, ketamine 10 mg, or both
  • Morphine sparing was measure of drug effect

38
Lo, et al, Anesthesiology 1998 89 A1163
39
Usually interactions are represented in two
dimensions
Adapted from Glass and Sebel
40
However, they are 3D surfaces(same model as on
prior slide)
41
Basic Concentration vs Response Relationship
1
0.8
0.6
50 Probability
Probability of no response
0.4
C
0.2
50
0
0.1
1
10
100
Drug concentration
42
Lowe Additivity
When normalized for potency, drug concentrations
can be simply added to calculate drug effect.
43
Lowe Additivity
44
Basis of Response Surface A Sigmoid in Every
Slice
45
How a response surface relates to an isobole
46
Simple Additivity
47
Synergy
48
Antagonism
49
Agonist-Partial Agonist
50
Agonist-Antagonist
51
Agonist-Inverse Agonist
52
Midazolam, Propofol, Alfentanil Interaction
  • 400 patients undergoing gynecological surgery
  • Dose response relationships established for loss
    of response to verbal command
  • All drugs tested singly, in paired combinations,
    and the triple drug combination.

Minto et al, Anesthesiology 2000 921603-16
53
Propofol-Midazolam Interaction for LOC
54
Midazolam-Alfentanil Interaction for LOC
55
Propofol-Alfentanil Interaction for LOC
56
Three Drug Model Simple Additivity
All C
All A
All B
57
Three Drug Model AB and AC Synergy, BC Additive
All C
All B
All A
58
Three Drug Model Triple Synergy
All C
All B
All A
59
Midazolam, Propofol, Alfentanil Interaction
60
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com